Morbidity and Mortality Weekly Report: MMWR, Volume 33U.S. Department of Health, Education, and Welfare, Public Health Service, Center for Disease Control, 1983 |
From inside the book
Results 6-10 of 51
Page 436
... Statistics Monographs . American Public Health Association . Cambridge : Harvard University Press 1970 : 36-57 . ( Continued on page 441 ) TABLE 1. Summary - cases specified notifiable diseases , United States Cumulative , 30th Week ...
... Statistics Monographs . American Public Health Association . Cambridge : Harvard University Press 1970 : 36-57 . ( Continued on page 441 ) TABLE 1. Summary - cases specified notifiable diseases , United States Cumulative , 30th Week ...
Page 457
... statistical power of the study . In all , 4,929 mothers of case - group babies and 3,029 mothers of control - group babies completed interviews ; fewer fathers completed interviews - 3,977 from the case group and 2,426 from the control ...
... statistical power of the study . In all , 4,929 mothers of case - group babies and 3,029 mothers of control - group babies completed interviews ; fewer fathers completed interviews - 3,977 from the case group and 2,426 from the control ...
Page 458
... statistical tests are done , some exceptions are expected . Some of this study's exceptions are noted below . The estimated risks for fathering babies with spina bifida ( imperfectly formed spinal cord ) were higher for Vietnam veteran ...
... statistical tests are done , some exceptions are expected . Some of this study's exceptions are noted below . The estimated risks for fathering babies with spina bifida ( imperfectly formed spinal cord ) were higher for Vietnam veteran ...
Page 465
... Statistics , Monthly Vital Statistics Report ( MVSR ) , Vol . 31 , No. 13 , October 5 , 1983 . National Center for Health Statistics , Monthly Vital Statistics Report ( MVSR ) , Vol . 33 , No. 4 , July 26 , 1984 , pp . 8-9 . IMS America ...
... Statistics , Monthly Vital Statistics Report ( MVSR ) , Vol . 31 , No. 13 , October 5 , 1983 . National Center for Health Statistics , Monthly Vital Statistics Report ( MVSR ) , Vol . 33 , No. 4 , July 26 , 1984 , pp . 8-9 . IMS America ...
Page 467
... Statistics Quarterly . 1980 ; 33 : 197-224 . Notice to Readers Availability of NIOSH Manual of Analytical Methods , Third Edition The National Institute for Occupational Safety and Health ( NIOSH ) has announced that volumes 1 and 2 of ...
... Statistics Quarterly . 1980 ; 33 : 197-224 . Notice to Readers Availability of NIOSH Manual of Analytical Methods , Third Edition The National Institute for Occupational Safety and Health ( NIOSH ) has announced that volumes 1 and 2 of ...
Other editions - View all
Common terms and phrases
Acquired Immunodeficiency Syndrome age group Alaska animal antibody Ariz Calif cancer Centers for Disease City Civilian clinical Colo Congenital rubella syndrome Conn cryptosporidiosis death Department of Health Disease Control E.S. CENTRAL Editorial Note Encephalitis Epidemiologic exposure Gonorrhea Guam Hawaii hemophilia Hepatitis hospital human illness immunization Immunodeficiency Syndrome AIDS increased infants infection influenza isolates Kans Legionellosis Leptospirosis lowa Malaria Mass measles MID ATLANTIC Minn MMWR Mortality Weekly Report Mumps Nebr NIOSH occurred Ohio Okla Oreg outbreak Pa.t Pac Trust Terr PACIFIC patients persons Pertussis Poliomyelitis population Primary & Secondary Psittacosis Public Health rabies Reporting Area risk RMSF Rubella specified notifiable diseases surveillance symptoms Syphilis Tenn tick-borne Total Toxic Shock syndrome Trichinosis Tuberculosis Tularemia Typhus fever U.S. Government Printing Unavailable TABLE United Upstate Utah vaccine Viral virus Wash weeks ending WN CENTRAL
Popular passages
Page 11 - National Center for Health Statistics. NCHS growth curves for children birth- 18 years. United States. Rockville, MD: National Center for Health Statistics. 1977. (Vital and health statistics. Series 1 1: Data from the National Health Survey, no.
Page 397 - Corticosteroids, other immunosuppressive agents, and immunosuppressive illnesses can interfere with the development of active immunity and predispose the patient to developing rabies. Immunosuppressive agents should not be administered during postexposure therapy, unless essential for the treatment of other conditions. When rabies post-exposure prophylaxis is administered to persons receiving steroids or other immunosuppressive therapy, it is especially important that serum be tested for rabies antibody...
Page 633 - ... authority to convey the warnings to the vaccinee, parent, guardian, or other responsible person of the possibility of vaccine-associated paralysis, particularly to susceptible family members and other close personal contacts. The Centers for Disease Control report that during 1972 to 1983, approximately 278.8 million OPV doses were distributed in the United States. During this same period, 87 vaccine-associated cases in apparently immunologically normal individuals were reported. Thirty-two occurred...
Page 397 - Two cases of neurologic illness resembling Guillain-Barre syndrome*'* a transient neuroparalytic illness, that resolved without sequelae in 12 weeks and a focal subacute central nervous system disorder temporally associated with HDCV, have been reported.
Page 437 - In: Remington JS, Klein JO, eds. Infectious diseases of the fetus and newborn infant. Philadelphia: WB Saunders, 1983:636-678.
Page 597 - Human cryptosporidiosis in immunocompetent and immunodeficient persons: studies of an outbreak and experimental transmission.
Page 397 - Once initiated, rabies prophylaxis should not be interrupted or discontinued because of local or mild systemic adverse reactions to rabies vaccine. Usually such reactions can be successfully managed with anti-inflammatory and antipyretic agents (eg aspirin). Reactions after vaccination with HDCV are less common than with previously available vaccines.
Page 398 - ... Category C. Animal reproduction studies have not been conducted with IMOVAX RABIES Vaccine. It is also not known whether the product can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. Rabies vaccine should be given to a pregnant woman only if clearly needed. Because of the potential consequences of inadequately treated rabies exposure and limited data that indicate that fetal abnormalities have not been associated with rabies vaccination, pregnancy...
Page 557 - Hypertension detection and follow-up program cooperative group. Fiveyear findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension.
Page 392 - ... bite a person should be captured and observed for symptoms of rabies for 10 days. If symptoms do not develop, the animal may be assumed to be non-rabid. If the animal dies or is killed, its head, undamaged, should be sent promptly, under refrigeration but not frozen, to a public health laboratory. Any wild animal that bites or scratches a person should be killed at once and the head kept under refrigeration during transportation to a public health laboratory. Rubber gloves should be worn by the...